We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

QuidelOrtho

Develops, manufactures and markets rapid diagnostic tests that focus on infectious diseases, reproductive health, and... read more Featured Products: More products

Download Mobile App





QuidelOrtho Presents Flexible Solutions for Quality Diagnostic Results Across Healthcare Continuum

By LabMedica International staff writers
Posted on 30 Jul 2025

QuidelOrtho Corporation (San Diego, CA, USA) is demonstrating its advanced diagnostic laboratory solutions and participating in a featured ADLM session on how Six Sigma insights can improve lab performance. More...

At ADLM 2025, QuidelOrtho is demonstrating how its flexible and reliable solutions can deliver quality diagnostic results across the entire healthcare continuum – from home to hospital, lab to clinic. QuidelOrtho is highlighting its VITROS Automation Solutions, which, combined with VITROS chemistry and immunoassay systems, can deliver high-quality results faster than VITROS systems alone. QuidelOrtho is also showcasing the VITROS XT 7600 Integrated system, which offers a full clinical chemistry and immunoassay menu in one easy-to-use system that delivers industry-leading uptime. Built-in technologies improve efficiency and quality, allowing for scalable automation solutions that streamline laboratory workflow. Additionally, QuidelOrtho is highlighting the VITROS XT 3400 system, which is powered by intelligent technologies and digital imaging technology to help labs meet routine testing needs and deliver proven high-quality results and system reliability in a small footprint.

Also featuring at this year’s ADLM is the Ortho Vision Max Swift automated immunohematology system, which can automate more than 99% of blood typing and antibody screening, without compromising turnaround time. Alongside, QuidelOrtho is featuring the Sofia 2 fluorescent immunoassay analyzer, built around the company’s proprietary fluorescence technology detection with an ultraviolet LED energy source. An optical sensor inside Sofia quickly scans and reliably collects hundreds of data points to generate actionable test results for the disease targets labs are seeking. QuidelOrtho is also highlighting its easy-to-use Quidel Triage system that provides the reliable diagnostic answers needed to make rapid, cost-effective treatment decisions at the point-of-care. With its comprehensive menu, the Quidel Triage system delivers lab-quality results at point-of-care speed.

Additionally, in a featured session at the ADLM meeting, QuidelOrtho and a panel of experts will be sharing how the company’s Six Sigma tools and real lab data can drive quality outcomes. For over 35 years, Six Sigma methodology and strategies have been used by businesses to improve manufacturing and operational quality and minimize variability. Sigma metrics have been adapted for the clinical laboratory by incorporating observed accuracy, precision, and total error allowed (TEa). Sigma metrics offer a valuable approach to quantifying quality. A higher sigma value corresponds to greater accuracy and precision in the measurements of processes being evaluated.

Related Links:
QuidelOrtho Corporation


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.